Histamine H4 receptor expression in triple negative breast cancer: an exploratory study
Abstract: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype. There are neither universally accepted prognostic markers, nor molecular targets related to TNBC. The histamine H4 receptor (H4R) has been characterized in TNBC experimental models, demonstrating its critical r...
Guardado en:
| Autores principales: | Speisky, Daniela, Táquez Delgado, Mónica Alejandra, Iott, Alejandro, Nicoud, Melisa Beatriz, Ospital, Ignacio, Vigovich, Félix, Dezanzo, Pablo, Ernst, Glenda, Uriburu, Juan Luis, Medina, Vanina Araceli |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés |
| Publicado: |
SAGE
2022
|
| Materias: | |
| Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/14023 |
| Aporte de: |
Ejemplares similares
-
Study of the antitumour effects and the modulation of immune response by histamine in breast cancer
por: Nicoud, Melisa Beatriz, et al.
Publicado: (2022) -
Nanomicellar formulations loaded with histamine and paclitaxel as a new strategy to improve chemotherapy for breast cáncer
por: Nicoud, Melisa Beatriz, et al.
Publicado: (2023) -
Immunomodulatory role of histamine H4 receptor in breast cancer
por: Sterle, Helena A., et al.
Publicado: (2019) -
Impact of histamine H4 receptor deficiency on the modulation of T cells in a murine breast cancer model
por: Nicoud, Melisa Beatriz, et al.
Publicado: (2022) -
Identification of resistance mechanism to targeting of the ADAM 17/ EGFR axis in triple negative breast cancer in vivo
por: Sharma, Neha
Publicado: (2015)